Enzalutamide in Japanese patients with chemotherapy‐naïve, metastatic castration‐resistant prostate cancer: A post‐hoc analysis of the placebo‐controlled PREVAIL trial

ConclusionTreatment effects and safety in Japanese patients were generally consistent with the overall results from PREVAIL.

Source: International Journal of Urology - February 29, 2016 Category: Urology & Nephrology Authors: Go Kimura, Junji Yonese, Takashi Fukagai, Tomomi Kamba, Kazuo Nishimura, Masahiro Nozawa, Hank Mansbach, Ad Theeuwes, Tomasz M Beer, Bertrand Tombal, Takeshi Ueda Tags: Original Article Source Type: research